Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 4, Pages 1654-1663
Publisher
American Society for Microbiology
Online
2013-01-19
DOI
10.1128/aac.01485-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
- (2012) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
- (2011) Jack Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
- (2011) R. Kullar et al. CLINICAL INFECTIOUS DISEASES
- Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns
- (2011) S. J. van Hal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
- (2011) Natasha E. Holmes et al. JOURNAL OF INFECTIOUS DISEASES
- Vancomycin Minimum Inhibitory Concentration and Outcome in Patients With Staphylococcus aureus Bacteremia: Pearl or Pellet?
- (2011) T. L. Holland et al. JOURNAL OF INFECTIOUS DISEASES
- Staphylococcus aureus:Methicillin‐SusceptibleS. aureusto Methicillin‐ResistantS. aureusand Vancomycin‐ResistantS. aureus
- (2010) Susan J. Rehm et al. CLINICAL INFECTIOUS DISEASES
- Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia
- (2010) Elizabeth A. Neuner et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Is vancomycin redundant for serious staphylococcal infection?
- (2010) Ian M. Gould INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Paradoxical Relationship between the Clinical Outcome ofStaphylococcus aureusBacteremia and the Minimum Inhibitory Concentration of Vancomycin
- (2009) James Price et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
- (2009) A. C. Musta et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used
- (2008) V. Prakash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model
- (2008) W. E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections
- (2008) Donald I. Hsu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2007) A. Soriano et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More